JOUT Q1 2026 Earnings EPS Slightly Exceeds Expectations Amid Sparse Revenue Disclosure TRIN Q1 2026 Earnings Slight EPS Beat Amid Modest Stock Decline HHS Q2 2025 Earnings Narrower Loss and Modest Stock Gain Amid Sparse Disclosures PANW Q1 2026 Earnings EPS Surpasses Estimates Stock Rises MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues